Reaction Details Report a problem with these data
Target
Galectin-3
Ligand
BDBM120769
Substrate
n/a
Meas. Tech.
Fluorescence Polarization-Based Assay
Kd
59000±n/a nM
Citation
 Leffler, H; Nilsson, UJ; Von Wachenfeldt, H Galactoside inhibitors of galectins US Patent  US8703720 Publication Date 4/22/2014 
Target
Name:
Galectin-3
Synonyms:
LEG3_HUMAN | LGALS3 | MAC2
Type:
Enzyme
Mol. Mass.:
26156.54
Organism:
Homo sapiens (Human)
Description:
P17931
Residue:
250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI
  
Inhibitor
Name:
BDBM120769
Synonyms:
US8703720, Reference Compound 2
Type:
Small organic molecule
Emp. Form.:
C15H27NO11
Mol. Mass.:
397.375
SMILES:
CO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@H](O)C1NC(C)=O |r|
Structure:
Search PDB for entries with ligand similarity: